amyloidosis/알부민

RELATED APPLICATIONS This application is a .sctn.371 national stage of PCT International Application No. PCT/EP2010/057235, filed May 26, 2010, claiming priority of European Patent Application No. EP 09382078.5, filed May 26, 2009, the contents of each of which are hereby incorporated by reference

FIELD OF THE INVENTION The invention relates to therapeutic compositions comprising albumin-amyloid peptide conjugates and uses thereof and, more specifically, to its use for the treatment of diseases associated with deposition of amyloid proteins, such as Alzheimer disease. BACKGROUND OF THE

CROSS-REFERENCE TO RELATED APPLICATION The present application is based on U.S. Provisional Patent Application No. 61/344,376 filed on Jul. 8, 2010. The contents of this U.S. Provisional Patent Application, literatures cited therein, and literatures described in the specification of the present

BACKGROUND OF THE INVENTION The present invention relates to ligand/anti-ligand assays for detection and measurement of adherent proteins, including lipophilic serum and plasma proteins, cytokines, globular serum and plasma proteins, and pentraxins. Assays of the present invention are particularly

BACKGROUND OF THE INVENTION The present invention relates to ligand/anti-ligand assays for detection and measurement of adherent proteins, including lipophilic serum and plasma proteins, cytokines, globular serum and plasma proteins, and pentraxins. Assays of the present invention are particularly

RELATED APPLICATIONS This application is a national stage application (under 35 U.S.C. .sctn.371) of PCT/DE2007/001427, filed Aug. 10, 2007, which claims benefit of German application 102006037613.7, filed Aug. 10, 2006 and German application 102006048249.2, filed Oct. 12, 2006. DESCRIPTION The